Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Binding properties of potent antileukemic drug STI-571 revealed

Sep. 25, 2000

NO-releasing agents for chemoprevention of colon cancer focus of NCI grant

Sep. 25, 2000

Zycos licenses gene-based oncology product

Sep. 25, 2000

Two recently issued patents cover Pfizer's new PTK inhibitors

Sep. 22, 2000

Roche and BMS form alliance to study Herceptin/Taxol anticancer combination

Sep. 22, 2000

IntraDose receives orphan drug status for melanoma indication

Sep. 22, 2000

Genta presents clinical trial update for Genasense

Sep. 22, 2000

Thalidomide improves tolerability of irinotecan in colorectal cancer patients

Sep. 22, 2000

Esculentins extracted from plant and found to exert antiinflammatory, antitumor effects

Sep. 21, 2000

2-5A antisense compound effective against malignant glioma and prostate cancer in mice

Sep. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...